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In 1993, Colborn et al. (1) pointed out that
large amounts of industrial-derived endo-
crine-disrupting chemicals have been
released into the environment since world
War II, and they hypothesized that prenatal
or early postnatal exposure to these com-
pounds could result in permanent and irre-
versible damage to wildlife and humans.
Several studies on wildlife populations have
documented adverse effects that correlate
with exposure to one or more putative
endocrine-disrupting chemicals (2-9); how-
ever, in many instances it is difficult to
assign causality because ofthe complexity of
environmental contaminants and the lack of
analytical data that document contaminant
levels during critical windows of exposure.
Nevertheless, there have been several inci-
dents in wildlife populations that strongly
correlate with exposure to specific industrial
chemicals; this includes alligators in Lake
Apopka, Florida, exposed to a spill of
organochlorine pesticides from a chemical
waste site (5,8,9). The alligators display a
host ofmorphologic and hormonally related
abnormalities ofthe male and female repro-
ductive tracts, including reduced penis size
in males. This reduced penis size in male
alligators (5,8,9) and a report (10) which
suggested that sperm counts had decreased
globally (from 113 x 106 to 66 x 106/mL)
during 1938-1990 generated considerable
public, media, regulatory, and scientific con-
cern about the possible role ofenvironmen-
tal exposures to endocrine disruptors and
their role in decreased male reproductive
capacity and breast cancer in women. In
1995, I critically reviewed the endocrine-dis-
ruptor hypothesis; based on the available
data, I was highly skeptical about the causal
linkage between exposure to environmental
(industrial-derived) endocrine disruptors and
adverse human health effects (11). Some of
this skepticism was related to the relatively
low levels ofexposure to synthetic endocrine
disruptors, particularly those with estrogenic
activity (xenoestrogens), as compared to high
dietary concentrations ofnaturally occurring
endocrine-active compounds in fruits and
vegetables and their derived food products.
Since 1995, the endocrine-disruptor
hypothesis has spurred new scientific studies
that address several relevant issues, and I
will highlight and discuss these in this
paper. In addition, the National Research
Council has published a comprehensive
report on "Hor-monally Active Agents in
the Environment" (12).
Wildlife and Laboratory
Animal Studies
The effects of environmental endocrine dis-
ruptors on wildlife populations are being
extensively investigated; adverse developmen-
tal and reproductive effects have been pri-
marily linked to organochlorine compounds
such as polychlorinated biphenyls (PCBs),
polychlorinated dibenzo-p-dioxins (PCDDs),
and polychlorinated dibenzofurans (PCDFs),
aswell asalkylphenols derived from alkylphe-
nol ethoxylate (AE) surfactants. Persistent
organochlorine pollutants (POPs), including
both pesticides such as DDT/DDE and
PCBs, were among the first industrial com-
pounds identified in the environment.
Moreover, with improvement of analytical
techniques, an ever-increasing number of
structurally diverse POPs have been detected
in environmental samples at low concentra-
tions (2,6,13,14). The use and production of
DDT and PCBs were restricted and banned
in most countries in the 1970s; however,
these compounds are still the most abundant
POPs in most wildlife and human samples,
even though their concentrations have sig-
nificantly decreased over the past 30 years
(14-16). Lower concentrations of POPs in
the Great Lakes region are correlated with
"dramatic improvements in reproductive
success and significant increases in popula-
tions ofcormorants, gulls, terns, herons and
other predatory birds in the Great Lakes
basin" (16).
There has been particular concern about
the discharge and environmental persistence
ofAEs and their alkylphenol degradation
products, which have been identified in rela-
tivelyhigh concentrations in industrial sewage
effluents and in sediments in lakes and rivers
in Europe (4,17-21). Concentrations ofthese
compounds in North American rivers and
sediments tend to be lower. Soto et al. (20)
showed that nonylphenols extracted from
polystyrene were estrogenic, and Jobling and
Sumpter (17) showed that the estrogen-regu-
lated yolk protein, vitellogenin, was induced
in male fish collected near sewage outflows in
the United Kingdom. Moreover, Fairchild et
al. (22) hypothesized that the estrogenic
effects of nonylphenol, a solvent/emulsifier
(an AE) used in pesticide spraying, may be
related to declines ofAtlantic salmon in
Atlantic Canada. The widespread estroge-
nized fish populations in British rivers and
estuaries have been extensively investigated
(23-25) and were initially linked to
nonylphenols and related compounds; how-
ever, the recent identification of etiologic
agents from sewage treatment effluents that
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received mainly domestic wastes was some-
whatsurprising (23,24). The majorestrogenic
components were the natural hormones 173-
estradiol (E2) and estrone, with minor
amounts of the birth control pill ingredient
17ct-ethinylestradiol. Routledge et al. (23)
concluded that
environmentally relevant concentrations of nat-
ural steroidal estrogens are sufficient to account
for the levels of vitellogenin synthesis observed
in caged male fish placed downstream ofcertain
[sewage treatment works] effluent discharges in
British rivers.
Thus, although initial concern regarding the
estrogenic disruption of fish in U.K. rivers
focused on synthetic estrogenic AE surfac-
tants, human and possible animal discharges
were the major sources ofthese environmen-
tal endocrine disruptors. This highlights the
difficulties in assigning causality to environ-
mental endocrine-disrupting chemicals with-
out thoroughly investigating all potentially
active agents.
Strong support for the endocrine-disrup-
tor hypothesis has come from laboratory ani-
mal studies where increasing numbers of
synthetic chemicals have been shown to
exhibit estrogenic/antiestrogenic, andro-
genic/antiandrogenic, and other endocrine-
likeactivities (6,26-33). Induded in thislistof
chemicals is p,p'-DDE, a major environmen-
tal contaminant thathas been shown to exhib-
it antiandrogenic activity in both in vivo and
in vitro models (28). Research from several
laboratories has shown that in utero exposure
to extremely low doses of 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD; < 1 pg/kg),
an aryl hydrocarbon receptor (AhR) agonist,
can result in a host of neurodevelopmental
and reproductive tract problems in juvenile
andadult rodent offspring (26,27,30-32).
Studies on in utero exposure to the estro-
genic drug diethylstilbestrol (DES) have
served as an important model for delineating
problems associated with exposure to estro-
genic compounds in both animal models and
in humans; DES-induced effects on the male
and female reproductive tracts strongly sup-
port the endocrine-disruptor hypothesis
(34,35). Bisphenol A, an important interme-
diate in the production ofpolycarbonates, is
a weakly estrogenic industrial compound in
most, but not all, assays (36-38). For exam-
ple, bisphenol A induces mammary gland
growth in Noble rats at doses as low as 0.1
mg/kg/day; this is similar to the dose
required for the potent estrogen DES to
induce the same response (34). The estro-
genic activity of bisphenol A in CF-1 mice
has also generated controversy (39-41); vom
Saal et al. (39) reported that fetal exposure to
lowdoses ofbisphenolA (2 or 20 pg/kg/day)
resulted in increased prostate weight in the
male offspring. Results for bisphenol A, E2,
and DES all gave low dose inverted U-shape
dose-response curves for this effect; at higher
doses, decreased prostateweightwas observed
in the offspring (39,40). In contrast, Cagen
et al. (41) did not observe this lowdose effect
for bisphenol A or DES in CF-1 mice. Thus,
the "low dose" hypothesis for this response
should be resolved for bisphenol A and other
estrogenic compounds.
Decreased Male Reproductive
Capacity and Endocrine
Disruptors
Sperm counts. The concern over decreased
sperm counts and male reproductive capaci-
ty was triggered by a paper on the meta-
analysis of 61 sperm count studies which
concluded that "There has been a genuine
decline in semen quality over the past 50
years" (10). This study (10) and a subse-
quent paper (42) hypothesized that
We argue that the increasing incidence ofrepro-
ductive abnormalities in the human male may be
related to increased oestrogen exposure in utero.
PCBs andTCDD-like compounds, as well as
DDE, may also contribute to this problem
(42,43). The validity of the meta-analysis
(10) was quickly debated (44-48), but more
importantly, new research on this problem
was initiated throughout the world. Results
ofsingle location and laboratory studies gave
highly variable results. Some reports showed
that over the last 15-25 years, there were sig-
nificant decreases in sperm quantity, whereas
other studies showed either no declines or
slight increases (49-58). Auger et al. (49)
investigated semen qualityamong fertile men
in Paris and reported that
The mean concentration ofsperm decreased by
2.1% per year from 86 x 106 per milliliter in
1973 to 60 x 106 per milliliter in 1992.
In contrast, using a similar approach, Bujan
et al. (50) reported that from 1977 to 1992,
"sperm concentration has not changed with
time in the Toulouse area." In 1996, Fisch et
al. (59) reported that semen quality of 1,283
men from three sperm banks in the United
States had not declined over the last 25 years
(1970-1995). The surprising results of this
studywere the large demographic differences
in sperm counts: sperm donors from New
York had the highest number (131.5 ± 3.5 x
106/mL, mean ± SEM), followed by
Minnesota (100.8 ± 2.9 x 106/mL) and
California (72.7 ± 3.1 x 106/mL).
In a separate study, Paulsen et al. (54)
reported no change in sperm counts in
Washington State between 1972 and 1993
(46.5 x 106/mL to 52 x 106/mL); by
accounting for geographic differences in an
analysis of 29 U.S. studies from 1938 to
1996, Saidi et al (60) reported "no significant
change in sperm counts during the last 60
years.` Geographic differences in sperm
counts have been reported in French men
(61) and Danish men (62) and also in a
Canadian study among 11 academic fertility
centers (63). The latter report shows that
among 48,968 samples ofsperm taken from
Canadian men between 1984 and 1996,
there was a significant overall downward
trend in sperm counts (63); however, when
the data from 1975 to 1983 were induded,
"there was no significant trend in sperm den-
sity" (63). Theanalysis ofdata from the indi-
vidual centers (1984-1996) showed that 6
centers had a downward trend and 5 centers
had small but insignificant increases in sperm
counts. However, the most remarkable
results from these studies were the differences
(geographic) between centers: in 1984, sperm
counts ranged from 51 x 106/mL to 121 x
106/mL, and in 1996, these values ranged
from 48 x 106/mL to 137 x 106/mL (63).
The predictive value of sperm count data
taken from self-selected volunteers is clearly
subject to multiple variables induding mea-
surement methods, temperatures, time of
day, and seasonal variability. Handelsman
(52) reported that mean sperm counts taken
from five different sets ofvolunteers at the
same hospital in Sydney, Australia, varied
from 142 x 106/mL to 63 x 106/mL, which
exceeded the differences in the decline in
sperm counts reported in the 1992 meta-
analysis by Carlsen et al. (10). Handelsman
(52 concluded that
This highlights the invalidity of extrapolating
similar findings on sperm counts ofselected vol-
unteers to the general male community or in
using such study groups to characterize sperm
counts insupposedlyhealthy men.
These data suggest that we do not know
if sperm counts are actually up or down.
Our knowledge of sperm counts and their
temporal variability in normal populations is
minimal, and the contributions ofthe envi-
ronment (i.e., lifestyle, diet, contaminants,
etc.) are also unknown.
Hypospadias and cryptorchidism.
Cryptorchidism is a condition in which one
or both testicles have not descended, and
hypospadias occurs when the urethral open-
ing is displaced. Both ofthese responses have
been observed in male offspring of rodents
exposed in uteroto estrogenic and antiandro-
genic compounds (64,65). Weidner et al.
(66) reported a significantly increased risk of
cryptorchidism, but not hypospadias, among
male offspring offemale (but not male) gar-
deners. This study suggests a possible link
between in utero exposure to agricultural
chemicals used in gardening; however, the
identity of potential toxic chemicals and
theirmodeofaction are unknown.
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Sharpe and Skakkebak (42), suggested
that decreased male reproductive capacity
may be related to exposure to endocrine dis-
ruptors (42), and pointed out that some
studies reported increases in hypospadias and
cryptochidism in male infants. Paulozzi (67)
analyzed international trends in rates of
cryptorchidism andhypospadias from several
different countries and categorized regions
by gross domestic product (in 1984).
Hypospadias increased in more affluent areas
but not in less affluent areas up to 1985,
whereas no increases have been observed
since 1985. Before 1985, there were also
region-specific trends in rates of cryp-
torchidism (increases in two U.S. and one
South American system); however, since
1985, rates have actually declined in most
systems (67). Thus, the specter of a global
decrease in male reproductive capacity is not
supported by international trends for
hypospadias or cryptorchidism; however,
like the sperm count data, there is some evi-
dence that incidence of these problems is
also dependent on demography.
Testicular cancer. Testicular cancer is
one of the major types of cancer in young
men, and there is evidence suggesting a pre-
natal etiology (68). Cryptorchidism is one of
the known risk factors for testicular cancer,
suggesting that in utero or early postnatal
exposure to estrogens or antiandrogens may
contribute to development ofthis tumor in
young men (68-72). Testicular cancer is
generally increasing in most countries, and it
was suggested thatp,p'-DDE, an antiandro-
gen, could play a role in the development of
this cancer (43). However, Ekbom et al.
(15) pointed out that DDE concentrations
in breast milk in the four Scandinavian
countries are not significantly different,
whereas the incidence of testicular cancer
(1985-1989) varies from 14.5/105 males in
Denmark (highest) to 3.6/105 males in
Finland (lowest). Moreover, as the overall
incidence of testicular cancer has increased
in all Scandinavian countries during the last
25-30 years, there has been an 80-90%
decrease in average breast milk DDE con-
centrations, showing an inverse relationship
between testicular cancer and DDE concen-
tration (15). Similar inverse correlation can
be observed in most other developed coun-
tries, includingthe United States (73). Many
countries in similar regions (e.g., bordering
the North Sea) do not have major differences
in human or environmental concentrations
ofpersistent organochlorine pollutants, and
differences in production and human expo-
sure to othersynthetic chemicals areunlikely.
Environmental exposures have not been
linked or correlated with testicular cancer,
and the environmental and lifestyle factors,
including diet and occupational exposures,
that are responsible for this disease are
unknown andshould beinvestigated.
Sex ratios and endocrine disruptors. A
recent study (74) reported that accidental
exposure to high concentrations ofTCDD
in Seveso resulted in lower sex ratios
(male/female) at birth; this observation has
been noted for high level occupational expo-
sures to some chemicals (74-76). There is
evidence from several countries, including a
recentU.S. study, that in thepastfewdecades
therehavebeensmall butsignificant decreases
in sex ratios (77-79). The potential role of
male/female sex ratios as sentinel health indi-
cators "that may be linked to environmental
factors" was proposed by Davis et al. (80),
based on their observations that the propor-
tionofmales born in Denmark (1950-1994),
The Netherlands (1950-1994), Canada
(1970-1990), and the United States (1970-
1990) had decreased. However, in the United
States, although theoverallsexratio decreased
from 1.053 in 1969 to 1.049 in 1995, this
small decline was observed only for Cau-
casians but not African Americans (77); the
authors conduded that "environmental expo-
sures are unlikely to account for the observed
trends." In a more recent comprehensive
study, Vartainen et al. (81) examined sex
ratios in Finland over the past 250 years.
From 1751 to 1920, there was an increase in
male/female birth ratios, and with the excep-
tion of pre- and post-World War I and II
years, there has been a dedine in these ratios
since 1920. Theauthorscondudedthat
the present data do not support the hypothesis
that agricultural or industrial environmental
estrogensplayanysignificant role
because, in Finland, major production and
exposures to these types of chemicals
occurred after 1950.James (82) initiallypro-
posed that newborn sex ratios may be a use-
ful indicator ofmale reproductive hazard but
hassubsequentlyconcluded that "population
sex ratios at birth are not useful monitors of
reproductivehazard."
Fertility. Temporal changes in human
fertility have not been extensively investigat-
ed; however, a recent study in Sweden (83)
concludedthat
adecrease in malefertility cannotbe ruled out ...
but ifpresent, it is minor and totallyoutweighed
byother favorabledevelopments.
Akre et al. (83) observed dedining infertility
among successive birth cohorts, and "this
strongly argues against a substantial deterio-
ration in sperm quality." This was explained
by the decreasing incidence ofgonorrhea
between 1970 and 1992. Previous studies
that demonstrated adverse effects ofDES on
male and female offspring are unquestion-
able (34,35); however, Wilcox et al. (84)
reported that fertility ofDES-exposed males
was not significantly different from males in
a control group. DES was not used in
Finland, but in a recent study, Hemminki et
al. (85) reported reproductive effects of in
utero exposure to estrogen and progestin
drugs on male and female offspring. There
were some differences in times of birth
between controls and hormone- or drug-
exposed individuals (e.g., time to first birth
after marriage, mean time between first and
second live birth); however, the overall fertil-
ity in both groups was similar. Hemminki et
al. (85) conduded that
Estrogen- and progestin-containing drugs as used
in the study population did not have much
impact onthefertility ofoffspring.
Thus, pharmacologic doses of estrogenic
drugs did not affect fertility, and it is unlike-
ly that much lower concentrations ofweakly
estrogenic industrial compounds would
affect fertility. Thus, with the exception of
testicular cancer, data from more recent
studies suggest that there does not appear to
be a worldwide decrease in disorders of the
male reproductive tract.
Xenoestrogens and Breast
Cancer
In 1992-1993, two studies from Connecticut
andNewYorkreportedhigherconcentrations
of PCBs and DDE, respectively, in breast
cancer patients as compared to controls
(86,87); this generated the hypothesis that
xenoestrogens, such as PCBs and DDE, were
preventable causes ofbreast cancer (88). This
hypothesis was supported by the two studies
on breast cancer patients (86,87) and also by
in vitro metabolic data on chemical-induced
metabolism of E2 to 2-hydroxyestrone (2-
OHEI) and 16ax-hydroxyestrone (16a-
OHE1) metabolites in MCF-7 human breast
cancer cells (89). The hypothesis ofDavis et
al. (88) was criticized on several counts (11),
and new research on the role oforganochlo-
rine contaminants in the incidence ofbreast
cancerhasdarifiedsomeoftheseissues.
PCB andDDE concentrations in breast
cancerpatients. I was particularly skeptical
about the biologic plausibility of the xenoe-
strogen hypothesis because occupational
exposures to high concentrations ofPCBs or
DDEhave not been associatedwith increased
risk for breast cancer (11). In rodent carcino-
gen-induced mammary cancer models, DDE
and 3,3',4,4'-tetrachlorobiphenyl both
increased and decreased mammary tumor for-
mation and growth (90-93), and the increase
in mammary tumor formation was primarily
associatedwith alteredcarcinogen metabolism
(91,92). Both TCDD and higher chlorinated
PCB mixtures inhibited formation ofsponta-
neous mammary tumors in 2-year-old female
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Sprague-Dawley rats (33,94); this was consis-
tent with the antiestrogenic activity associated
withAhRagonists in breast cancer (95,96).
Several recent studies on DDE and PCB
concentrations in breast cancer patients ver-
sus controls ha've been carried out in Europe,
Asia, North and South America, and most
studies indicate that levels of these organo-
chlorine contaminants are not significantly
different in the two groups (Table 1)
(97-106). These data are consistent with an
earlier report by Krieger et al. (107) in a
California cohort. Several studies have also
investigated risk for breast cancer and corre-
lations with other organochlorine com-
pounds or other parameters. For example,
Moyisch et al. (101,106) reported an odds
ratio (OR) of1.8 for women (parous women
who had never lactated) with high concen-
trations of hexachlorobenzene (HCB), but
Zheng et al. (108) did not observe higher
concentrations of HCB in patients in
Connecticut (304 cases and 186 controls)
and concluded that
our study does not support a positive association
between environmental exposure to HCB and
risk ofbreast cancer.
In a study in Copenhagen, Hoyer et al.
(102) reported that although correlations for
PCBs were not observed, the pesticide dield-
rin was associated with an increased risk for
breast cancer. The authors concluded that
these findings support the hypothesis that expo-
sure to xenoestrogens may increase the risk of
breast cancer.
Dieldrin is an exceedingly weak estrogen in
most assays, and the biologic plausibility that
trace concentrations of this contaminant
play a role in breast cancer is minimal. Some
recent studies have combined differences in
DDE or PCB concentrations with drug-
metabolizing enzyme polymorphisms in
breast cancer patients and control groups
(mixtures and congeners) to further investi-
gate correlations with breast cancer (106);
this approach in future studies may lead to
new insights.
Estrogen metabolite ratios. Bradlow et
al. (89) investigated the effects of various
chemicals, including several organochlorine
pesticides, on the metabolism of E2 to 2-
OHEI and 16a-OHE1 in MCF-7 human
breast cancer cells and concluded that "the
ratio of 16a-OHEI/2-OHEI may provide
a marker for the risk of breast cancer."
PCBs, DDE, and other weakly estrogenic
pesticides induced higher 166a-OHE1/2-
OHE1 ratios, and these data were initially
used to support the xenoestrogen hypothesis
in early reports showing higher concentra-
tions of PCBs or DDE in breast cancer
patients versus controls. The predictive util-
ity of the ratio was based on reports that
16a-OHE1 was highly estrogenic and high-
er levels ofthis metabolite were observed in
a small cohort of breast cancer patients
(89,109,110). In contrast, 2-OHE1 exhibits
partial antiestrogenic activity and was
labeled by Bradlow et al. as "the 'good'
estrogen" (110). In my laboratory, we used
the radiometric assay, as previously
described (89), to investigate the effects ofa
diverse spectrum ofestrogens, antiestrogens,
and mammary carcinogens on estrogen
metabolism (111,112). The results showed
that the metabolite ratios in our study were
not predictive of carcinogens, estrogens, or
antiestrogens, and metabolite ratios varied
with the concentration ofsome compounds
in this assay. For example, the triphenyleth-
ylene antiestrogen 4'-hydroxytamoxifen
decreased the ratio, whereas the potent
steroidal antiestrogen ICI 182,780 increased
the ratio; we also observed other inconsis-
tencies between compounds with similar
effects on mammary cancer (111,112). We
concluded that induction ofthis metabolite
ratio in MCF-7 breast cancer cells was not
predictive for a wide variety of chemicals
that may affect breast cancer in vivo (112).
Some additional studies question the use of
the urinary 16a-OHE1/2-OHE1 ratio as a
predictor of risk for breast cancer
(113-115). In a recent study, Ursin et al.
(115) reported that in 66 postmenopausal
breast cancer patients and 76 control
subjects,
the ratio of 2-OHEI to 16a-OHE1 was 1.1%
higher in the patients (p = 0.84) contrary to the
hypothesis.
The authors concluded that
this study does not support the hypothesis that
the ratio ofthe two hydroxylated metabolites (2-
OHEI/16ax-OHEI) is an important risk factor
for breast cancer.
Endocrine Disruptors in the
Diet
The potential adverse role ofendocrine dis-
ruptors in the diet during critical periods of
development will depend not only on intake
concentrations ofthese compounds but also
on their concentrations in serum and in the
fetus. Intake concentrations of synthetic
estrogenic compounds and AhR agonists are
low as compared to dietary intakes ofnatur-
al phytoestrogens and AhR-active com-
pounds (e.g., indole-3-carbinol) in fruits
and vegetables (11). In one collaborative
study, we compared the estrogenic potency
of one glass ofred wine (200 mL) with the
corresponding potency of the estimated
daily intake of organochlorine pesticide
residues in food (116) (Figure 1). The
reconstituted mixture in this study included
the following weakly estrogenic organochlo-
rine contaminants: 1,1,1-trichloro-2-(p-
chlorophenyl)-2-(o-chlorophenyl)ethane,
1, 1, 1-trichloro-2,2-bis(p-chloro-
phenyl)ethane, 1,1-dichloro-2,2-bis(p-
chlorophenyl)ethylene, endosulfan-1, endo-
sulfan-2, p,p'-methoxychlor, and toxaphene.
The relative proportion of each chemical in
the mixture resembled the composition
reported in a recent U.S. Food and Drug
Administration market basket survey (117).
Using a series ofseven in vitro assays, the cal-
culated estrogen equivalents (EQs) in extracts
from 200 mL red cabernet wine varied from
0.15 to 3.68 pg/day. In contrast, the EQs for
consumption of organochlorine pesticides
(2.44 ,ug/day) varied from nondetectable to
1.24 ng/day. These data, coupled with EQs
for other foods (118), demonstrate that
dietary intakes ofnaturally occurring phytoe-
strogens far exceed intakes oforganochlorine
xenoestrogens. However, these data should
not be overinterpreted because organochlo-
rine compounds bioaccumulate and can be
identified in serum and because dietary intake
levels ofotherxenoestrogens are unknown.
Table 1. Recent reports on PCB and DDE concentrations in breast cancer patients versus control groups.
DDE PCBs Serum
Reference Cases (n) Control (n) Cases (n) Control (n) fat (concentration)
vant' Veer et al. (98) 1.35 (265) 1.51 (341) V (pg/g) Hunter et al. (99 6.01 + 4.56 (236) 6.97 ± 4.56 (236) 5.08 ± 7.51 (236) 5.16 ± 2.26 (236) V (ng/ml)
Schecter et al. (100) 2.33 ± 0.46 (21) 2.37 ± 0.58 (21) - - V (ng/mL)
L6pez-Carrillo et al. (97) 4.75 (141) 4.07 (141) - - V(ng/mL)
Liljegren et al. (104) 0.767 (43) 1.026(35) 1.205(43) 1.149(335) V (pg/g) Guttes et al. (103) 0.805(45) 0.496 (20) 0.625 (45) 0.505(20) V (pg/g) Moysich et al. (101) 11.47 (154) 10.77 (192) 4.24 (154) 4.12 (192) V (ng/mL)
Hoyer et al.I102) 10.2 (240) 9.5(477) 8.6 (240) 8.7 (472) V (ng/mL) Hetzisouer et al. (105) 11.5± 7.1 (235) 13.6 ± 10.6 (235) 7.9 ± 6.4 (235) 9.7 ± 3.6 (235) V (ng/mL)
Moysich et al. (106) 7.9 ± 6.4(105) 9.7 ± 3.6 (105) 2.1 ± 2.0 (105) 2.2 ± 1.9(105) V )ng/mL)
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Figure 1. (A) Estrogen equivalents (EQs) in various food products and organochlorine compounds (OCs) (117) and (B) range of human serum concentrations of
natural estrogens, isoflavones, and OCs (116,119) in different groups. EQs (ng) were 0-1 for OC pesticides infood, 200-3,000for red wine, 200-1,000for beans, and
24,000for cabbage.
Recent reports have investigated serum
concentrations of some phytoestrogens
(119,120), and these can be compared to
endogenous hormone and organochlorine
xenoestrogen serum concentrations in human
populations. A recent study on women in
Long Island, New York, showed that total
serum concentrations oforganochlorine pes-
ticides plus PCBs were < 10 ng/mL (121);
these values correspond to serum concentra-
tions from women sampled within the last
5-10 years (Table 1). Setchell et al. (119)
recentlysummarized serum concentrations of
endogenous estrogenic hormones in men,
women, and children as well as concentra-
tions of estrogenic isoflavones in various
groups. Serum concentrations ofestradiol in
men, women, and neonates are variable
(between 10 and 500 pg/mL); however, con-
centrations in maternal blood andcord blood
are similar to concentrations oforganochlo-
rine compounds (10,000 pg/mL). On the
basis ofthe low estrogenic potencies ofthese
xenoestrogens, it is unlikely that their effects
as estrogens are important. This does not
exclude endocrine- andestrogen-independent
toxic actions oforganochlorine compounds
that are currently beinginvestigated inseveral
laboratories. Serum concentrations ofestro-
genic isoflavones (primarily genistein,
daidzein, and equol) can range from 552,000
to 1,755,000 pg/mL (mean = 988,000
pg/mL) in soy-fed infants; these are approxi-
mately 100-fold higher than organochlorine
concentrations (119). High isoflavone con-
centrations (- 100,000 pg/mL) have also
been detected in Japanese men (119,120).
Thus, on the basis ofcurrent analytical data,
soy-fed infants are the group with the highest
exposure to estrogenic compounds during
critical periods ofdevelopment. Most studies
associate consumption ofphytoestrogen-con-
taining foods with health benefits (122,123);
however, as reported bySetchell etal. (119,
To allay increasing concerns about soy-based for-
mulas, long-term follow-up studies are needed to
assess the potential beneficial or adverse effects of
phyto-oestrogen exposure inearly life.
Summary
Environmental concentrations of persistent
organochlorine compounds have been
decreasing over the past two decades, and
this correlates with remarkable advances in
the detection of exceedingly low levels of
these compounds in human populations.
Undoubtedly, correlational studies ofhuman
diseases with tissue and serum concentra-
tions of organochlorine compounds will
continue, and due to the large number of
these compounds, positive correlations with
some diseases will undoubtedly be made. It
is important that interpretation of data
obtained from these studies consider biologic
plausibility and temporal trends in concen-
trations as well as additional correlative
results from other reports.
Results of recent studies suggest that
there is not a global decrease in male repro-
ductive capacity and that an etiologic role
for xenoestrogens in female breast cancer is
unlikely. It is possible that new scientific
evidence may reinforce or weaken these
conclusions; it is also important to carefully
validate and replicate findings before media
announcements that may contribute to
unnecessary fear and worry by the public. A
recent book, The Culture ofFear (124), has
addressed some of the issues regarding
unreasonable fears bythepublic; it states,
We compound our worries beyond all reason.
Life expectancy in the United States has doubled
during the twentieth century. We are better able
to cure and control diseases than any other civi-
lization in history. Yet, we hear that phenomenal
numbers ofus are dreadfully ill.
The role of endocrine disruptors and
human disease has not been fully resolved;
however, at present the evidence is not
compelling.
Note: A recentpaper by many ofthe same coauthors
ofthe sperm count meta-analysis study (10) have
now reported "a significant increase in mean sperm
concentrationfrom 53.Ox 1J(/mL in 1977to 72.7
x 106l/mL in 1995" among donors to the Central
Sperm Bank in Copenhagen (125).
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